Abstract
Background
The SARS-CoV-2 pandemic has had a significant impact on healthcare, including eye care, worldwide. Effective and safe vaccines have been developed using both conventional and novel technologies to combat SARS-CoV-2 infection. While vaccination has been shown to be remarkably effective in reducing the spread and associated morbidity and mortality of COVID-19 disease, there have been reports of complications to the posterior segment of the eye.
Methods
We present a case-based analysis of reported complications of COVID-19 vaccination to the posterior segment of the eye. The study aims to highlight the diversity of possible complications and discuss the plausible involved pathophysiologic mechanisms.
Results
The most significant complications reported were retinal macro or microvascular occlusions, uveitis, and central serous chorioretinopathy. These complications are rare but require prompt diagnosis and management to prevent serious visual morbidity.
Conclusions
Our study highlights the need for ophthalmologists to be aware of possible complications related to COVID-19 vaccination and the importance of prompt diagnosis and management. The findings of this study may help ophthalmologists to better understand and manage these rare complications.
Similar content being viewed by others
Availability of data and materials
The data supporting this study’s findings are available from the corresponding author upon reasonable request.
References
Zenker S, Kock F (2020) The coronavirus pandemic—a critical discussion of a tourism research agenda. Tour Manag 81:104164
Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF (2021) Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol 21(10):626–636
Ozonoff A, Nanishi E, Levy O (2021) Bell’s palsy and SARS-CoV-2 vaccines. Lancet Infect Dis 21(4):450–452
Rallis KI, Ting DSJ, Said DG, Dua HS (2022) Corneal graft rejection following COVID-19 vaccine. Eye 36(6):1319–1320. https://doi.org/10.1038/s41433-021-01671-2
Saraceno JJF et al (2021) Vogt-Koyanagi-Harada syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. Int J Retina Vitreous 7(1):1–7
Bayas A et al (2021) Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. The Lancet 397(10285):e11
Khani E, Entezari-Maleki T (2022) Hypertensive crisis following COVID-19 vaccination
Angeli F, Reboldi G, Trapasso M, Verdecchia P (2022) Hypertension after COVID-19 vaccination. G Ital Cardiol 23(1):10–14. https://doi.org/10.1714/3715.37055
Oniszczuk J et al (2021) Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2. Kidney Int 100(4):940
Paulsen F-O et al (2021) Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19). J Am Soc Hematol 138(11):996–999
Park HS et al (2021) Retinal hemorrhage after SARS-CoV-2 vaccination. J Clin Med 10(23):5705
Merritt LD (2021) Reports of bleeding and thrombocytopenia reported to VAERS after Moderna and Pfizer COVID-19 Vaccinations. J Am Phys Surg 26(2):51–54
Amin MA, Nahin S, Dola TA, Afrin S, Hawlader MDH (2022) Retinal hemorrhage of late post-COVID-19 and post-vaccine-related pathogenic mechanisms: a new challenge for ophthalmologist in COVID era. Clin Case Rep 10(2):e05471
Mechleb N, Khoueir Z, Assi AJ (2022) Bilateral multifocal central serous retinopathy following mRNA COVID-19 vaccine. J Fr Ophtalmol 45:603–607
Jamali H, Sadeghi E, Nowroozzadeh MH (2022) Suprachoroidal hemorrhage during phacoemulsification surgery associated with recent COVID-19: a report of two cases, vol 10. Wiley, New York, p e6204
Mechleb N, Khoueir Z, Assi A (2022) Bilateral multifocal central serous retinopathy following mRNA COVID-19 vaccine. J Fr Ophtalmol 45(6):603–607. https://doi.org/10.1016/j.jfo.2022.02.001
de Bruijn S et al (2021) First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination. J Thromb Haemost 19(8):2014–2018
Pichi F et al (2021) Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi. JAMA Ophthalmol 139(10):1131–1135
Fowler N, Martinez NRM, Pallares BV, Maldonado RS (2021) Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep 23:101136
Lee DY, Wu HJ, Cheng KC, Chang YC (2021) Disc edema in one eye and central serous chorioretinopathy in the other eye shortly after AstraZeneca COVID-19 vaccination. Kaohsiung J Med Sci 38:283
Bolletta E et al (2021) Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med 10(24):5960
Jampol LM, Tauscher R, Schwarz HP (2021) COVID-19 vaccinations, and subsequent abnormalities in the retina: causation or coincidence? JAMA Ophthalmol 139(10):1135–1136
Girbardt C et al (2021) Retinal vascular events after mRNA and adenoviral-vectored COVID-19 vaccines—a case series. Vaccines 9(11):1349
Pur DR, Catherine Danielle Bursztyn LL, Iordanous Y (2022) Branch retinal vein occlusion in a healthy young man following mRNA COVID-19 vaccination. Am J Ophthalmol Case Rep 26:101445. https://doi.org/10.1016/j.ajoc.2022.101445
Kang MS, Kim SY, Kwon HJ (2022) Case report: recanalization of branch retinal artery occlusion due to microthrombi following the first dose of SARS-CoV-2 mRNA vaccination. Front Pharmacol 13:837
Abdin AD, Gärtner BC, Seitz B (2022) Central retinal artery occlusion following COVID-19 vaccine administration. Am J Ophthalmol Case Rep 26:101430. https://doi.org/10.1016/j.ajoc.2022.101430
Peters MC, Cheng SSH, Sharma A, Moloney TP (2022) Retinal vein occlusion following COVID-19 vaccination. Clin Exp Ophthalmol 50(4):459–461. https://doi.org/10.1111/ceo.14056
Ikegami Y et al (2022) Combined central retinal artery and vein occlusion shortly after mRNA-SARS-CoV-2 vaccination. QJM 114(12):884–885. https://doi.org/10.1093/qjmed/hcab287
Lee S, Sankhala KK, Bose S, Gallemore RP (2022) Combined central retinal artery and vein occlusion with ischemic optic neuropathy after COVID-19 vaccination. Int Med Case Rep J 157:7–14
Invernizzi A et al (2020) Retinal findings in patients with COVID-19: results from the SERPICO-19 study. EClin Med 27:100550
Da Silva LS et al (2022) Vascular retinal findings after COVID-19 vaccination in 11 cases: a coincidence or consequence? Arq Bras Oftalmol 85:158–165
Valenzuela DA, Groth S, Taubenslag KJ, Gangaputra S (2021) Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination. Am J Ophthalmol Case Rep 24:101200. https://doi.org/10.1016/j.ajoc.2021.101200
Azar G et al (2021) Did the COVID-19 pandemic increase the incidence of acute macular neuroretinopathy? J Clin Med 10(21):5038
Mambretti M et al (2021) Acute macular neuroretinopathy following coronavirus disease 2019 vaccination. Ocul Immunol Inflamm 29(4):730–733
Drüke D, Pleyer U, Hoerauf H, Feltgen N, Bemme S (2021) Acute macular neuroretinopathy (AMN) following COVID-19 vaccination. Am J Ophthalmol Case Rep 24:101207
Goyal M, Murthy SI, Annum S (2021) Retinal manifestations in patients following COVID-19 infection: a consecutive case series. Indian J Ophthalmol 69(5):1275
Scharf J, Freund KB, Sadda S, Sarraf DJ (2021) Sarraf DJ (2021) Paracentral acute middle maculopathy and the organization of the retinal capillary plexuses. Prog Retin Eye Res 81:100884
Vinzamuri S, Pradeep TG, Kotian RJ (2021) Bilateral paracentral acute middle maculopathy and acute macular neuroretinopathy following COVID-19 vaccination. Indian J Ophthalmol 69(10):2862
Maleki A, Look-Why S, Manhapra A, Foster CS (2021) Research v. COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: Real or coincidence? J Ophthalmic Vis Res 16(3):490
Testi I, Brandão-de-Resende C, Agrawal R, Pavesio CJ (2022) Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect 12(1):1–6
Mishra SB, Mahendradas P, Kawali A, Sanjay S, Shetty R (2021) Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID 19 vaccination in an Asian Indian male. Eur J Ophthalmol 33(1):NP32–NP36. https://doi.org/10.1177/11206721211046485
Rabinovitch T et al (2021) Uveitis after the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association. Retina 41(12):2462–2471
Tomishige KS, Novais EA, Finamor LP, Nascimento HM, Belfort R Jr (2022) Multiple evanescent white dot syndrome (MEWDS) following inactivated COVID-19 vaccination (Sinovac-CoronaVac). Arq Bras Oftalmol 85:186–189
Atas F, Kaya M, Saatci AO (2021) Acute multifocal placoid pigment epitheliopathy-like presentation following the first dose of BNT162B2 COVID-19 vaccination. Ocul Immunol Inflamm 31:220–223
Chen X, Wang B, Li X (2022) Acute-onset Vogt–Koyanagi–Harada like uveitis following COVID-19 inactivated virus vaccination. Am J Ophthalmol Case Rep 26:101404
Murtaza F, Pereira A, Mandelcorn MS, Kaplan AJ (2022) Vogt–Koyanagi–Harada disease following influenza vaccination. Am J Ophthalmol Case Rep 26:101516. https://doi.org/10.1016/j.ajoc.2022.101516
Campos WR, Cenachi SPF, Soares MS, Goncalves PF, Vasconcelos-Santos DV (2021) Vogt–Koyanagi–Harada-like disease following yellow fever vaccination. Ocul Immunol Inflamm 29(1):124–127. https://doi.org/10.1080/09273948.2019.1661498
Sood AB, O’Keefe G, Bui D, Jain N (2019) Vogt–Koyanagi–Harada disease associated with hepatitis B vaccination. Ocul Immunol Inflamm 27(4):524–527. https://doi.org/10.1080/09273948.2018.1483520
Shariati MM et al (2022) Uveitis including Vogt–Koyanagi–Harada syndrome following inactive covid-19 vaccination: a case series. J Ophthalmic Inflamm Infect 13:1–8
Koong LR et al (2021) Vogt-Koyanagi-Harada disease associated with COVID-19 mRNA vaccine. Ocul Immunol Inflamm 29(6):1212–1215
Reddy Y, Pandey A, Ojha A, Ramchandani S (2022) Harada-like syndrome post-Covishield vaccination: a rare adverse effect. Indian J Ophthalmol 70(1):321
Kim SY, Kang MS, Kwon HJ (2022) Bilateral panuveitis mimicking Vogt–Koyanagi–Harada disease following the first dose of ChAdOx1 nCoV-19 vaccine. Ocul Immunol Inflamm 30:1–4
Ishay Y et al (2021) Autoimmune phenomena following SARS-CoV-2 vaccination. Int Immunopharmacol 99:107970
Mudie LI, Zick JD, Dacey MS, Palestine AG (2021) Panuveitis following vaccination for COVID-19. Ocul Immunol Inflamm 29(4):741–742
Lee BA et al (2022) Presumed panuveitis following COVID-19 vaccination in a patient with granulomatous tattoo inflammation. Ret Cases Brief Rep. https://doi.org/10.1097/ICB.0000000000001248
Khochtali S et al (2021) Multimodal imaging of acute foveolitis following COVID-19 vaccination. Ocul Immunol Inflamm 30(5):1214–1217
Hasegawa T, Sannomiya Y, Toyoda M, Maruko I, Iida T (2022) Acute idiopathic maculopathy after COVID-19 vaccination. Am J Ophthalmol Case Rep 26:101479. https://doi.org/10.1016/j.ajoc.2022.101479
Goyal M, Murthy SI, Annum S (2021) Bilateral multifocal choroiditis following COVID-19 vaccination. Ocul Immunol Inflamm 29(4):753–757
Younus O, Mulla U (2022) Posterior scleritis following COVID-19 vaccination: a case report. Ocul Immunol Inflamm 31:1–3
Chen PJ, Chang YS, Lim CC, Lee YK (2022) Susac syndrome following COVID-19 vaccination: a case report. Vaccines. https://doi.org/10.3390/vaccines10030363
Papasavvas I, Herbort CP (2021) Reactivation of Vogt–Koyanagi–Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflamm Infect 11(1):1–6
Xu Y, Shen W (2021) Presumed recurrent MEWDS following Covid-19 vaccination. Ocul Immunol Inflamm 29(6):1234–1237. https://doi.org/10.1080/09273948.2021.1985524
Pang K, Pan L, Guo H, Wu X (2022) Case report: associated ocular adverse reactions with inactivated COVID-19 vaccine in China. Front Med 8:823346
Achiron A, Tuuminen R (2022) Severe panuveitis with iridis rubeosis activation and cystoid macular edema after BioNTech-Pfizer COVID-19 vaccination in a 17-year-old. Am J Ophthalmol Case Rep 25:101380
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
Conceptualization; Elham Sadeghi and M. Hossein Nowroozzadeh; Data curation; Raziyeh Mahmoudzadeh and Sunir J. Garg; Formal analysis; Elham Sadeghi and M. Hossein Nowroozzadeh; Investigation; Raziyeh Mahmoudzadeh and Sunir J. Garg; Methodology; Elham Sadeghi and M. Hossein Nowroozzadeh; Project administration; M. Hossein Nowroozzadeh; Resources; Raziyeh Mahmoudzadeh and Sunir J. Garg; Software; Raziyeh Mahmoudzadeh and Sunir J. Garg; Supervision; M. Hossein Nowroozzadeh; Validation; Raziyeh Mahmoudzadeh and Sunir J. Garg; Visualization; Elham Sadeghi and M. Hossein Nowroozzadeh; Writing—original draft; Elham Sadeghi and M. Hossein Nowroozzadeh; Writing—review & editing: Raziyeh Mahmoudzadeh and Sunir J. Garg.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
The article does not involve any data from subjects. Hence exempted from prior patient consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sadeghi, E., Mahmoudzadeh, R., Garg, S.J. et al. Ocular posterior segment complications following COVID-19 vaccination. Int Ophthalmol 43, 4343–4357 (2023). https://doi.org/10.1007/s10792-023-02795-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-023-02795-y